Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00322062Phase 3Completed
Phase 3, randomised, single-blind trial of macrogol in colonoscopy (2 arms), sponsored by Norgine. Primary endpoint: Overall quality of colonoscopy prep. Started Apr 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00322062.